General Information of the Protein
Protein ID
PT01156
Protein Name
Muscarinic acetylcholine receptor M4
Gene Name
CHRM4
Sequence
MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGNILVMLSIKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTVYIIKGYWPLGAVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPARRTTKMAGLMIAAAWVLSFVLWAPAILFWQFVVGKRTVPDNQCFIQFLSNPAVTFGTAIAAFYLPVVIMTVLYIHISLASRSRVHKHRPEGPKEKKAKTLAFLKSPLMKQSVKKPPPGEAAREELRNGKLEEAPPPALPPPPRPVADKDTSNESSSGSATQNTKERPATELSTTEATTPAMPAPPLQPRALNPASRWSKIQIVTKQTGNECVTAIEIVPATPAGMRPAANVARKFASIARNQVRKKRQMAARERKVTRTIFAILLAFILTWTPYNVMVLVNTFCQSCIPDTVWSIGYWLCYVNSTINPACYALCNATFKKTFRHLLLCQYRNIGTAR
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Small molecule receptor (family A GPCR)
>
Monoamine receptor
>
Acetylcholine receptor
Function
The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is inhibition of adenylate cyclase.
    Show/Hide
Uniprot ID
Primary ID:
P08173

Secondarily ID:
B2RPP4
Q0VD60
Q4VBK7
    Show/Hide
Ensembl ID
ENSG00000180720
HGNC ID
HGNC:1953
Subcellular Location
Cell membrane
Postsynaptic cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000398 , A-9
Compound ID Compound Name Compound Formula
CP0847519
5-{4-[2-(2-{2-[2-(4-Methoxy-[1,2,5]thiadiazol-3-yloxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-[1,2,5]thiadiazol-3-yl}-1-methyl-1,2,3,6-tetrahydro-pyridine hydrochloride
   Show/Hide
C19H30ClN5O6S2
 2
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
2
Ki = 2.512 nM
   TI
   LI
   LO
   TS
CP0371787
5-(4-Hexyloxy-[1,2,5]thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine; oxalic acid
   Show/Hide
C14H23N3OS
 2
1
IC50 = 25.12 nM
   TI
   LI
   LO
   TS
2
Ki = 39.81 nM
   TI
   LI
   LO
   TS
CP0635477
(2-Carbamoyloxy-ethyl)-trimethyl-ammonium chloride
   Show/Hide
C6H15ClN2O2
 2
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
2
Ki = 398.11 nM
   TI
   LI
   LO
   TS
CP0376259
1-[4-(1-methyl-1,2,3,6-tetrahydro-5-pyridinyl)-1,2,5-thiadiazol-3-yloxy]-2-[2-(2-{2-[4-(1-methyl-1,2,3,6-tetrahydro-5-pyridinyl)-1,2,5-thiadiazol-3-yloxy]ethoxy}ethoxy)ethoxy]ethane
   Show/Hide
C24H36N6O5S2
 1
1
Ki = 1.995 nM
   TI
   LI
   LO
   TS
CP0179471
3-methoxy-4-[2-[2-[2-[2-[[4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazol-3-yl]oxy]ethoxy]ethoxy]ethoxy]ethoxy]-1,2,5-thiadiazole
   Show/Hide
C19H29N5O6S2
 1
1
Ki = 2.512 nM
   TI
   LI
   LO
   TS
CP0739672
penta(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether
   Show/Hide
C21H33N5O7S2
 1
1
Ki = 12.59 nM
   TI
   LI
   LO
   TS
CP0846924
5-{4-[12-(4-Methoxy-[1,2,5]thiadiazol-3-yloxy)-dodecyloxy]-[1,2,5]thiadiazol-3-yl}-1-methyl-1,2,3,6-tetrahydro-pyridine
   Show/Hide
C23H37N5O3S2
 1
1
Ki = 19.95 nM
   TI
   LI
   LO
   TS
CP0781215
tetra(ethylene glycol)(3-methoxy-1,2,4-thiadiazol-5-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether
   Show/Hide
C19H29N5O6S2
 1
1
Ki = 25.12 nM
   TI
   LI
   LO
   TS
CP0853783
12-[4-(1-Methyl-1,2,5,6-tetrahydro-pyridin-3-yl)-[1,2,5]thiadiazol-3-yloxy]-dodecan-1-ol hydrochloride
   Show/Hide
C20H36ClN3O2S
 1
1
Ki = 31.62 nM
   TI
   LI
   LO
   TS
CP0847850
di(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether
   Show/Hide
C15H21N5O4S2
 1
1
Ki = 63.1 nM
   TI
   LI
   LO
   TS
CP0847854
tri(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether
   Show/Hide
C17H25N5O5S2
 1
1
Ki = 79.43 nM
   TI
   LI
   LO
   TS
CP0849748
Acetic acid 12-[4-(1-methyl-1,2,5,6-tetrahydro-pyridin-3-yl)-[1,2,5]thiadiazol-3-yloxy]-dodecyl ester hydrochloride
   Show/Hide
C22H38ClN3O3S
 1
1
Ki = 79.43 nM
   TI
   LI
   LO
   TS
CP0847851
tri(propylene glycol)(3-methoxy-1,2,4-thiadiazol-5-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether
   Show/Hide
C19H25N5O5S2
 1
1
Ki = 158.49 nM
   TI
   LI
   LO
   TS
CP0847853
tri(propylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether
   Show/Hide
C19H25N5O5S2
 1
1
Ki = 158.49 nM
   TI
   LI
   LO
   TS
CP0847381
2-(2-(2-(2-(4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yloxy)ethoxy)ethoxy)ethoxy)ethanol
   Show/Hide
C16H27N3O5S
 1
1
Ki = 794.33 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0037621
(oxotremorine)1-(4-Pyrrolidin-1-yl-but-2-ynyl)-pyrrolidin-2-one
   Show/Hide
C12H18N2O
 1
1 EC50 = 33 nM
CP0635477
(2-Carbamoyloxy-ethyl)-trimethyl-ammonium chloride
   Show/Hide
C6H15ClN2O2
 3
1 EC50 = 75 nM
2 IC50 = 7200 nM
3 Ki = 7600 nM
CP0224773
3-amino-N-(2,3-difluorobenzyl)-4-methyl-6-(4-pyridylmethoxy)thieno[2,3-b]pyridine-2-carboxamide
   Show/Hide
C22H18F2N4O2S
 1
1 EC50 = 95 nM
CP0018455
1-methyl-3,6-dihydro-2H-pyridine-5-carboxylic acid methyl ester;hydrobromide
   Show/Hide
C8H13NO2
 3
1 EC50 = 130 nM
2 IC50 = 13500 nM
3 Ki = 60000 nM
CP0180462
3-amino-4,6-dimethyl-N-p-anisyl-thieno[2,3-b]pyridine-2-carboxamide
   Show/Hide
C18H19N3O2S
 2
1 EC50 = 520 nM
2 EC50 = 680 nM
CP0673968
SID50106181
   Show/Hide
C21H26INO2
 6
1 IC50 = 0.61 nM
2 IC50 = 0.83 nM
3 IC50 = 1.1 nM
4 IC50 = 1.9 nM
5 Ki = 0.37 nM
6 Ki = 0.66 nM
CP0049755
(R)-1-Aza-bicyclo[2.2.2]oct-3-yl-[(Z)-methoxyimino]-acetonitrile
   Show/Hide
C10H15N3O
 1
1 IC50 = 90 nM
CP0317131
(9bS)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydroimidazo[2,1-a]isoindol-5-one
   Show/Hide
C23H15ClF2N2O2
 1
1 IC50 > 30000 nM
CP0067390
ethyl 6-butyl-17-methoxy-12-oxa-1,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),5,9,14(19),15,17-heptaene-5-carboxylate
   Show/Hide
C26H30N2O4
 1
1 Ki = 1 nM
CP0164673
2,2-Diphenyl-propionic acid 2-diethylamino-ethyl ester
   Show/Hide
C21H27NO2
 1
1 Ki = 7.4 nM
CP0067391
(2R)-1-((2S,4R)-4-hydroxy-1-[3,3,3-tris(4-fluorophenyl)propanoyl]pyrrolidine-2-yl)carbonyl-N-(4-piperidinylmethyl)pyrrolidine-2-carboxamide
   Show/Hide
C37H41F3N4O4
 1
1 Ki = 42 nM
CP0025667
2-[4-(4-Methyl-benzyl)-piperazin-1-yl]-1-(2-methyl-2,3-dihydro-indol-1-yl)-ethanone
   Show/Hide
C18H19ClN4
 1
1 Ki = 100 nM
CP0056034
11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
   Show/Hide
C19H21N5O2
 1
1 Ki = 105 nM
CP0040250
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol
   Show/Hide
C21H25N3O2S
 1
1 Ki = 1000 nM
CP0045063
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
   Show/Hide
C17H20N4S
 1
1 Ki = 1000 nM
CP0026924
N-[1-[3-(3-oxo-1,4-benzoxazin-4-yl)propyl]piperidin-4-yl]-2-phenylacetamide
   Show/Hide
C24H29N3O3
 1
1 Ki >= 1000 nM
CP0029624
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
   Show/Hide
C20H31NO
 1
1 Ki >= 1000 nM
Clinical Information about the Protein
Target 1 ( Muscarinic acetylcholine receptor M4 (CHRM4) )
Target Type Successful Target
Disease 5 Target-related Diseases  5
1 Glaucoma/ocular hypertension [ICD-11: 9C61]
2 Nausea [ICD-11: MD90]
3 bronchial hyperreactivity [ICD-11: CB40]
4 Mydriasis [ICD-11: LA11.62]
5 Attention deficit hyperactivity disorder [ICD-11: 6A05.Z]
Approved Drug(s) 4 Approved Drugs  4
1 ACECLIDINE Approved
Glaucoma/ocular hypertension
2 Diphenidol Approved
Nausea
3 Methacholine Chloride Approved
bronchial hyperreactivity
4 Tropicamide Approved
Mydriasis
Investigative Drug(s) 1 Investigative Drug  1
1 PF-3409409 Investigative
Attention deficit hyperactivity disorder
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT01736 Muscarinic acetylcholine receptor M4 Rattus norvegicus, Rat